Stockholm-listed, Sweden-based international healthcare and diagnostic services company, Medicover, has signed a new €450m (US$526m) syndicated revolving credit facility agreement. The new facility replaces the existing €300m revolving credit facility dated June 2022.
The new oversubscribed facility has a maturity of three years with two one-year extension options subject to lenders‘ approval.
Nordea was coordinating bookrunner and mandated lead arranger (MLA), documentation agent and facility agent. Erste Bank Polska, ING, Landesbank Hessen-Thüringen, Raiffeisen and SEB acted as bookrunners and MLA. Bank Pekao, Oldenburgische Landesbank and UniCredit acted as MLA.
In 2025, Medicover reported revenue growth of 13.7% to €2.4bn (€2.1bn in 2024). Ebitda growth was €371m, up 30.2%, from €285m in 2024.
Press release: Press releases | Medicover
